Researchers believe that focused high doses of radiotherapy could one day replace surgery for small cancers in certain organs.
New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.
Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.
Our Science Surgery series answers your cancer science questions. Read our answer to Patrick’s question.
Step inside a virtual world where our Grand Challenge scientists are hoping to redefine the way we look at cancer.
Our researchers in Glasgow might have found a way to shut down certain cancer cells’ fuel supply with a specially designed diet.
Find out how our scientists are developing a way to target a troublesome cancer molecule, LOX.
Our rapid turn-around funding scheme aims to fund high-risk research that we wouldn’t normally fund.
New research predicts that 2 in 3 cancers are ‘due to bad luck’, we look at why the story is a bit more complicated than that.